Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma.
Li Q, Wang W, Machino Y, Yamada T, Kita K, Oshima M, Sekido Y, Tsuchiya M, Suzuki Y, Nan-Ya K, Iida S, Nakamura K, Iwakiri S, Itoi K, Yano S.
Li Q, et al.
Cancer Sci. 2015 Jan;106(1):102-7. doi: 10.1111/cas.12575. Epub 2014 Dec 18.
Cancer Sci. 2015.
PMID: 25421609
Free PMC article.